{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T20:23:06Z","timestamp":1751314986550,"version":"3.37.3"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Conducting functional assessments remotely can help alleviate the burden of in-person assessment on patients with Duchenne muscular dystrophy and their caregivers. The objective of this study was to evaluate whether scores from remote functional assessment of patients with Duchenne muscular dystrophy correspond to in-person scores on the same functional assessments. Remote live stream versus in-person scores on the North Star Ambulatory Assessment (including time [seconds] to complete the 10-meter walk\/run and time to rise from the floor [supine to stand]) were assessed using statistical analyses, including intraclass correlation coefficient, and Pearson, Spearman, and Bland-Altman analyses. The remote and in-clinic assessments had to occur within 2 weeks of one another to be considered for this analysis. This analysis included patients with Duchenne muscular dystrophy, aged 4 to 7 years. Participants in this analysis received delandistrogene moxeparvovec (as part of SRP-9001-101 [Study 101; NCT03375164] or SRP-9001-102 [Study 102; NCT03769116]) or were randomized to receive placebo (in Part 1 of Study 102). This study evaluates score reproducibility between live stream remote scoring versus in-person functional assessments as determined by intraclass correlation coefficient, and Pearson, Spearman, and Bland-Altman analyses. The results showed that scores from remote functional assessment of patients with Duchenne muscular dystrophy strongly correlated with those obtained in person. These findings demonstrate congruence between live stream remote and in-person functional assessment and suggest that remote assessment has the potential to reduce the burden on a family by supplementing in-clinic visits.<\/jats:p>","DOI":"10.1371\/journal.pone.0300700","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T17:59:01Z","timestamp":1715882341000},"page":"e0300700","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validity of remote live stream video evaluation of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4206-0557","authenticated-orcid":true,"given":"Linda","family":"P. Lowes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay N.","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2800-3855","authenticated-orcid":true,"given":"Megan A.","family":"Iammarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie F.","family":"Reash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Giblin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0644-5954","authenticated-orcid":true,"given":"Rachel","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry R.","family":"Mendell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"issue":"10","key":"pone.0300700.ref001","doi-asserted-by":"crossref","first-page":"18168","DOI":"10.3390\/molecules201018168","article-title":"Duchenne Muscular Dystrophy: From Diagnosis to Therapy.","volume":"20","author":"MS Falzarano","year":"2015","journal-title":"Molecules"},{"issue":"6","key":"pone.0300700.ref002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/DBP.0000000000000177","article-title":"Neurobehavioral Concerns Among Males with Dystrophinopathy Using Population-Based Surveillance Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network.","volume":"36","author":"K Caspers Conway","year":"2015","journal-title":"J Dev Behav Pediatr."},{"issue":"11","key":"pone.0300700.ref003","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1177\/0883073815570154","article-title":"Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy","volume":"30","author":"R Banihani","year":"2015","journal-title":"J Child Neurol"},{"key":"pone.0300700.ref004","first-page":"S63","article-title":"DMD & BMD\u2013CLINICAL: P.54 Has the time to diagnosis of Duchenne muscular dystrophy improved? Data from the Muscular dystrophy surveillance, tracking, and research network.","volume":"30","author":"E Ciafaloni","year":"2020","journal-title":"Neuromuscular Disord."},{"issue":"3","key":"pone.0300700.ref005","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jpeds.2009.02.007","article-title":"Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).","volume":"155","author":"E Ciafaloni","year":"2009","journal-title":"J Pediatr"},{"issue":"5","key":"pone.0300700.ref006","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jpeds.2014.07.006","article-title":"Motor and cognitive delay in Duchenne muscular dystrophy: implication for early diagnosis","volume":"165","author":"KT Mirski","year":"2014","journal-title":"J Pediatr"},{"issue":"3","key":"pone.0300700.ref007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.","volume":"17","author":"DJ Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"pone.0300700.ref008","first-page":"5","article-title":"Age at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet","volume":"9","author":"E Ciafaloni","year":"2016","journal-title":"J Pediatr Rehabil Med"},{"issue":"1","key":"pone.0300700.ref009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","article-title":"Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?","volume":"16","author":"S Kourakis","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"pone.0300700.ref010","first-page":"9","article-title":"Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy.","volume":"31","author":"C Angelini","year":"2012","journal-title":"Acta Myol."},{"issue":"11","key":"pone.0300700.ref011","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.nmd.2016.08.011","article-title":"Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy","volume":"26","author":"C Tian","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"pone.0300700.ref012","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1469-8749.2002.tb00272.x","article-title":"Fracture prevalence in Duchenne muscular dystrophy.","volume":"44","author":"DG McDonald","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"9","key":"pone.0300700.ref013","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","article-title":"Bone mineral density and bone metabolism in Duchenne muscular dystrophy","volume":"14","author":"ML Bianchi","year":"2003","journal-title":"Osteoporos Int"},{"issue":"1","key":"pone.0300700.ref014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nmd.2004.09.009","article-title":"Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention","volume":"15","author":"R Quinlivan","year":"2005","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"pone.0300700.ref015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0960-8966(01)00307-8","article-title":"Vertebral compression in Duchenne muscular dystrophy following deflazacort","volume":"12","author":"B Talim","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"pone.0300700.ref016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41582-019-0203-3","article-title":"Therapeutic developments for Duchenne muscular dystrophy.","volume":"15","author":"IEC Verhaart","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"pone.0300700.ref017","doi-asserted-by":"crossref","first-page":"1167762","DOI":"10.3389\/fcell.2023.1167762","article-title":"Expression of SRP-9001 dystrophin and stabilization of motor function up to 2 years post-treatment with delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy","volume":"11","author":"JR Mendell","year":"2023","journal-title":"Front Cell Dev Biol"},{"year":"2023","author":"US Food and Drug Administration.","journal-title":"ELEVIDYS(TM) Highlights of prescribing information","key":"pone.0300700.ref018"},{"unstructured":"UAE Ministry of Health & Prevention 2023. Available from: https:\/\/mohap.gov.ae\/en\/services\/registered-medical-product-directory. Accessed February 2024.","key":"pone.0300700.ref019"},{"issue":"2","key":"pone.0300700.ref020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000517411","article-title":"First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases.","volume":"5","author":"L Servais","year":"2021","journal-title":"Digit Biomark"},{"key":"pone.0300700.ref021","doi-asserted-by":"crossref","first-page":"735538","DOI":"10.3389\/fgene.2021.735538","article-title":"Remote Delivery of Motor Function Assessment and Training for Clinical Trials in Neuromuscular Disease: A Response to the COVID-19 Global Pandemic.","volume":"12","author":"MK James","year":"2021","journal-title":"Front Genet."},{"year":"2020","author":"US Food and Drug Administration","journal-title":"Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency: Guidance for Industry, Investigators, and Institutional Review Boards","key":"pone.0300700.ref022"},{"year":"2022","author":"European Commission","journal-title":"Guidance on the management of clinical trials during the COVID-19 (coronavirus) pandemic","key":"pone.0300700.ref023"},{"year":"2022","author":"US Food and Drug Administration","journal-title":"Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials guidance for industry","key":"pone.0300700.ref024"},{"issue":"6","key":"pone.0300700.ref025","doi-asserted-by":"crossref","first-page":"e26004","DOI":"10.2196\/26004","article-title":"Developing Digital Tools for Remote Clinical Research: How to Evaluate the Validity and Practicality of Active Assessments in Field Settings.","volume":"23","author":"J Ferrar","year":"2021","journal-title":"J Med Internet Res"},{"issue":"2","key":"pone.0300700.ref026","first-page":"149","article-title":"The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials","volume":"87","author":"V Ricotti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"year":"2020","journal-title":"North Star Ambulatory Assessment","article-title":"Great Ormond Street Hospital NHS Foundation Trust & The Newcastle upon Tyne Hospitals NHS Foundation Trust","key":"pone.0300700.ref027"},{"issue":"5","key":"pone.0300700.ref028","first-page":"728","article-title":"Evaluating the Feasibility and Reliability of Remotely Delivering and Scoring the North Star Ambulatory Assessment in Ambulant Patients with Duchenne Muscular Dystrophy.","volume":"9","author":"N Emery","year":"2022","journal-title":"Children (Basel)."},{"issue":"9","key":"pone.0300700.ref029","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial","volume":"77","author":"JR Mendell","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"pone.0300700.ref030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mus.27955","article-title":"Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1\/2a nonrandomized trial","volume":"69","author":"JR Mendell","year":"2024","journal-title":"Muscle Nerve"},{"issue":"4","key":"pone.0300700.ref031","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s43441-019-00006-4","article-title":"Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.","volume":"54","author":"M Apostolaros","year":"2020","journal-title":"Ther Innov Regul Sci."},{"issue":"5","key":"pone.0300700.ref032","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/cts.12834","article-title":"Remote Monitoring in Clinical Trials During the COVID-19 Pandemic.","volume":"13","author":"ES Izmailova","year":"2020","journal-title":"Clin Transl Sci."},{"issue":"8","key":"pone.0300700.ref033","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.nmd.2017.05.013","article-title":"Reliability and validity analyses of the North Star Ambulatory Assessment in Brazilian Portuguese","volume":"27","author":"LO Okama","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"pone.0300700.ref034","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1017\/S1355617721001053","article-title":"Equivalency of In-Person Versus Remote Assessment: WISC-V and KTEA-3 Performance in Clinically Referred Children and Adolescents.","volume":"28","author":"T Hamner","year":"2022","journal-title":"J Int Neuropsychol Soc."},{"issue":"12","key":"pone.0300700.ref035","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1044\/2020_JSLHR-20-00202","article-title":"Taking Language Samples Home: Feasibility, Reliability, and Validity of Child Language Samples Conducted Remotely With Video Chat Versus In-Person","volume":"63","author":"BL Manning","year":"2020","journal-title":"J Speech Lang Hear Res"},{"issue":"7\u20138","key":"pone.0300700.ref036","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/1357633X19845278","article-title":"Remote neuropsychological assessment of elderly Japanese population using the Alzheimer\u2019s Disease Assessment Scale: A validation study","volume":"26","author":"K Yoshida","year":"2020","journal-title":"J Telemed Telecare"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0300700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T17:59:27Z","timestamp":1715882367000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0300700"}},"subtitle":[],"editor":[{"given":"Giulio","family":"Piluso","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0300700","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,5,16]]}}}